EyeYon ^{For Profit}

EyeYon Medical develops innovative technologies to heal corneas and preserve the vision of millions of patients worldwide. The company is positioned at the forefront of ophthalmology, breaking barriers for corneas, the most common organ transplant worldwide. Their flagship technology, EndoArt®, is the first synthetic implant to treat corneal edema and save vision while eliminating the need for human donor tissue. EyeYon's Hyper-CL™ therapeutic contact lens provides a novel solution for the treatment of corneal conditions, increasing bioavailability of any topical drop. The company collaborates with leading ophthalmologists worldwide, including Prof. Gerd U. Auffarth, Prof. Merab Dvali, Dr. Naftali Modi, Prof. Irit Barequet, Prof. Francis Mah, Prof. Lional Raj, Dr. Boris Knyazer MD, Dr. Moshe Mendelson, Dr. Navneet Toshniwal, and Dr. Nitin Toshniwal. EyeYon Medical is inventing a clearer future for vision for all. Contact_info: Not available on the website.